Whittier Trust Co. of Nevada »

Seres Therapeutics shares owned by Whittier Trust Co. of Nevada

Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Whittier Trust Co. of Nevada from 13F filings

Historical chart of Whittier Trust Co. of Nevada investment in Seres Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seres Therapeutics held by Whittier Trust Co. of Nevada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seres Therapeutics by Whittier Trust Co. of Nevada

Quarter filed Position value Share count Share price at filing
2026-06-30 $8 1 8.00

More positions owned by Whittier Trust Co. of Nevada

Nvidia Corp common (NVDA)
Apple Computer common (AAPL)
Alphabet common (GOOG)
Microsoft Corp common (MSFT)
Amazon.com common (AMZN)
SPDR S&P 500 common (SPY)
Ishares S&p 500 common (IVV)
Jp Morgan Chase common (JPM)
Broadcom common (AVGO)
I Shares S&p Mid 400 common (IJH)
Ishares Emerg-iemg common (IEMG)
Vanguard Ftse Intl common (VEA)
Visa common (V)
Vang Emerg Mkt Etf common (VWO)
Berkshire Clb common (BRK.B)

View all positions for Whittier Trust Co. of Nevada

Top funds holding Seres Therapeutics

Flagship Ventures Management
Vanguard Capital Management
Marshall Wace
Susquehanna International
Vontobel Holding
BlackRock
Geode Capital Management
Citadel Advisors
Vanguard Fiduciary Trust
State Street Corporation
Lion Point Capital
Charles Schwab Investment Management
Sixth Street Partners Management Company
American Century Companies
Morgan Stanley

View all funds holding Seres Therapeutics